{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:00:58Z","timestamp":1794488458215,"version":"4.9.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"vor","delay-in-days":75,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.vaccine.2023.05.063","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T12:50:18Z","timestamp":1686833418000},"page":"4571-4578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Incidence and clinical outcomes of pneumonia in persons with down syndrome in the United States"],"prefix":"10.1016","volume":"41","author":[{"given":"Edward N.","family":"Janoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Fu","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamuno","family":"Alfred","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Vietri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angee","family":"McDaniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Chilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul E.","family":"Isturiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myron J.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.vaccine.2023.05.063_b0005","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1056\/NEJMra1706537","article-title":"Down syndrome","volume":"382","author":"Bull","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2023.05.063_b0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s11689-019-9306-9","article-title":"Health comorbidities and cognitive abilities across the lifespan in Down syndrome","volume":"12","author":"Startin","year":"2020","journal-title":"J Neurodev Disord"},{"issue":"4","key":"10.1016\/j.vaccine.2023.05.063_b0015","doi-asserted-by":"crossref","first-page":"572","DOI":"10.7326\/M20-4986","article-title":"COVID-19 mortality risk in down syndrome: Results from a cohort study of 8 million adults","volume":"174","author":"Clift","year":"2020","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.vaccine.2023.05.063_b0020","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.humimm.2016.05.004","article-title":"Altered immune parameters correlate with infection-related hospitalizations in children with Down syndrome","volume":"77","author":"Martinez","year":"2016","journal-title":"Hum Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2023.05.063_b0025","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3201\/eid1608.091931","article-title":"Pandemic (H1N1) 2009 virus and Down syndrome patients","volume":"16","author":"Perez-Padilla","year":"2010","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2023.05.063_b0030","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ridd.2011.09.026","article-title":"Morbidity and hospitalizations of adults with Down syndrome","volume":"33","author":"Tenenbaum","year":"2012","journal-title":"Res Dev Disabil"},{"issue":"52","key":"10.1016\/j.vaccine.2023.05.063_b0035","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.1016\/j.vaccine.2013.09.070","article-title":"Functionality of the pneumococcal antibody response in Down syndrome subjects","volume":"31","author":"Kusters","year":"2013","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2023.05.063_b0040","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.celrep.2019.10.038","article-title":"Mass cytometry reveals global immune remodeling with multi-lineage hypersensitivity to type I interferon in down syndrome","volume":"29","author":"Waugh","year":"2019","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2023.05.063_b0045","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/eji.201445049","article-title":"Reduced numbers of switched memory B cells with high terminal differentiation potential in Down syndrome","volume":"45","author":"Carsetti","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2023.05.063_b0050","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3389\/fimmu.2020.00840","article-title":"Immune Defect in Adults With Down Syndrome: Insights Into a Complex Issue","volume":"11","author":"Dieudonne","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2023.05.063_b0055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fped.2020.00073","article-title":"Immune dysregulation in children with down syndrome","volume":"8","author":"Huggard","year":"2020","journal-title":"Front Pediatr"},{"issue":"4","key":"10.1016\/j.vaccine.2023.05.063_b0060","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1440-1754.1999.00386.x","article-title":"Respiratory morbidity of hospitalized children with Trisomy 21","volume":"35","author":"Hilton","year":"1999","journal-title":"J Paediatr Child Health"},{"issue":"Pt 12","key":"10.1016\/j.vaccine.2023.05.063_b0065","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1365-2788.2007.01013.x","article-title":"Hospitalizations of infants and young children with Down syndrome: evidence from inpatient person-records from a statewide administrative database","volume":"51","author":"So","year":"2007","journal-title":"J Intellect Disabil Res"},{"issue":"3","key":"10.1016\/j.vaccine.2023.05.063_b0070","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/jir.12572","article-title":"Hospitalisation of adults with Down syndrome: lesson from a 10-year experience from a community hospital","volume":"63","author":"Chenbhanich","year":"2019","journal-title":"J Intellect Disabil Res"},{"issue":"4","key":"10.1016\/j.vaccine.2023.05.063_b0075","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ajmg.a.35706","article-title":"Changes in mortality and causes of death in the Swedish Down syndrome population","volume":"161A","author":"Englund","year":"2013","journal-title":"Am J Med Genet A"},{"issue":"4","key":"10.1016\/j.vaccine.2023.05.063_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.dhjo.2020.100947","article-title":"Cause of death in adults with Down syndrome in the United States","volume":"13","author":"Landes","year":"2020","journal-title":"Disabil Health J"},{"key":"10.1016\/j.vaccine.2023.05.063_b0085","unstructured":"COVID-19 and Down Syndrome Resources. Global Down Syndrome Foundation. Available at: https:\/\/www.globaldownsyndrome.org\/wp-content\/uploads\/2021\/11\/COVID-DS-RESOURCE-11.22.2021-ENGLISH.pdf. Accessed March 30, 2022."},{"issue":"4","key":"10.1016\/j.vaccine.2023.05.063_b0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.15585\/mmwr.mm7104a1","article-title":"Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among u.s. . Adults: updated recommendations of the advisory committee on immunization practices - united states, 2022","volume":"71","author":"Kobayashi","year":"2022","journal-title":"Adults MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2023.05.063_b0095","unstructured":"Child and Adolescent Immunization Schedule by Medical Indication. CDC. Available at: https:\/\/www.cdc.gov\/vaccines\/schedules\/hcp\/imz\/child-indications.html. Accessed March 30, 2022."},{"issue":"1","key":"10.1016\/j.vaccine.2023.05.063_b0100","doi-asserted-by":"crossref","first-page":"ofu024","DOI":"10.1093\/ofid\/ofu024","article-title":"Rates of pneumococcal disease in adults with chronic medical conditions","volume":"1","author":"Shea","year":"2014","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2023.05.063_b0105","doi-asserted-by":"crossref","first-page":"356","DOI":"10.2337\/dc17-1096","article-title":"How does empagliflozin reduce cardiovascular mortality? Insights from a mediation analysis of the empa-reg outcome trial","volume":"41","author":"Inzucchi","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.vaccine.2023.05.063_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.621440","article-title":"Immune dysregulation and the increased risk of complications and mortality following respiratory tract infections in adults with down syndrome","volume":"12","author":"Illouz","year":"2021","journal-title":"Front Immunol"},{"issue":"627","key":"10.1016\/j.vaccine.2023.05.063_b0115","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abi4888","article-title":"Deep immune phenotyping reveals similarities between aging, Down syndrome, and autoimmunity","volume":"14","author":"Lambert","year":"2022","journal-title":"Sci Transl Med"},{"issue":"48","key":"10.1016\/j.vaccine.2023.05.063_b0120","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1016\/j.vaccine.2015.10.083","article-title":"Generation of switched memory B cells in response to vaccination in Down syndrome children and their siblings","volume":"33","author":"Valentini","year":"2015","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2023.05.063_b0125","doi-asserted-by":"crossref","first-page":"L892","DOI":"10.1152\/ajplung.00434.2020","article-title":"Lung disease manifestations in Down syndrome","volume":"321","author":"Danopoulos","year":"2021","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2023.05.063_b0130","doi-asserted-by":"crossref","first-page":"A6","DOI":"10.1016\/j.vaccine.2020.09.048","article-title":"The disease burden of influenza beyond respiratory illness","volume":"39","author":"Macias","year":"2021","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2023.05.063_b0135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13023-018-0989-x","article-title":"Infection risk among adults with down syndrome: a two group series of 101 patients in a tertiary center","volume":"14","author":"Guffroy","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2023.05.063_b0140","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/cid\/ciab375","article-title":"Expanded analysis of 20 pneumococcal serotypes associated with radiographically confirmed community-acquired pneumonia in hospitalized us adults","volume":"73","author":"Isturiz","year":"2021","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23006242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23006242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:29:25Z","timestamp":1759404565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23006242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":28,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0264410X23006242"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.05.063","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and clinical outcomes of pneumonia in persons with down syndrome in the United States","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.05.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}